These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 21454027)

  • 1. Beneficial effect of pyruvate therapy on Leigh syndrome due to a novel mutation in PDH E1α gene.
    Koga Y; Povalko N; Katayama K; Kakimoto N; Matsuishi T; Naito E; Tanaka M
    Brain Dev; 2012 Feb; 34(2):87-91. PubMed ID: 21454027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A family with pyruvate dehydrogenase complex deficiency due to a novel C>T substitution at nucleotide position 407 in exon 4 of the X-linked Epsilon1alpha gene.
    Tulinius M; Darin N; Wiklund LM; Holmberg E; Eriksson JE; Lissens W; De Meirleir L; Holme E
    Eur J Pediatr; 2005 Feb; 164(2):99-103. PubMed ID: 15558317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The SR protein SC35 is responsible for aberrant splicing of the E1alpha pyruvate dehydrogenase mRNA in a case of mental retardation with lactic acidosis.
    Gabut M; Miné M; Marsac C; Brivet M; Tazi J; Soret J
    Mol Cell Biol; 2005 Apr; 25(8):3286-94. PubMed ID: 15798212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pyruvate dehydrogenase deficit associated to the C515T mutation in exon 6 of the E1alpha gene].
    Blanco-Barca O; Gomez-Lado C; Rodrigo-Saez E; Curros-Novos C; Briones-Godino P; Eiris-Punal J; Castro-Gago M
    Rev Neurol; 2006 Sep 16-30; 43(6):341-5. PubMed ID: 16981164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potential of dichloroacetate for pyruvate dehydrogenase complex deficiency.
    Berendzen K; Theriaque DW; Shuster J; Stacpoole PW
    Mitochondrion; 2006 Jun; 6(3):126-35. PubMed ID: 16725381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled clinical trial of dichloroacetate for treatment of congenital lactic acidosis in children.
    Stacpoole PW; Kerr DS; Barnes C; Bunch ST; Carney PR; Fennell EM; Felitsyn NM; Gilmore RL; Greer M; Henderson GN; Hutson AD; Neiberger RE; O'Brien RG; Perkins LA; Quisling RG; Shroads AL; Shuster JJ; Silverstein JH; Theriaque DW; Valenstein E
    Pediatrics; 2006 May; 117(5):1519-31. PubMed ID: 16651305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of pyruvate metabolism disorders by culture of skin fibroblasts with dichloroacetate.
    Naito E; Kuroda Y; Takeda E; Yokota I; Kobashi H; Miyao M
    Pediatr Res; 1988 Jun; 23(6):561-4. PubMed ID: 2839811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Leigh syndrome due to pyruvate dehydrogenase E1 alpha subunit gene mutation: a complicated and difficult case study].
    Zhang Y; Sun F; Yang YL; Chang XZ; Qi Y; Qi ZY; Xiao JX; Qin J; Wu XR
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Jun; 9(3):216-9. PubMed ID: 17582259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance spectroscopic investigation of mitochondrial fuel metabolism and energetics in cultured human fibroblasts: effects of pyruvate dehydrogenase complex deficiency and dichloroacetate.
    Simpson NE; Han Z; Berendzen KM; Sweeney CA; Oca-Cossio JA; Constantinidis I; Stacpoole PW
    Mol Genet Metab; 2006; 89(1-2):97-105. PubMed ID: 16765624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic treatment of mitochondrial disease patients with dichloroacetate.
    Barshop BA; Naviaux RK; McGowan KA; Levine F; Nyhan WL; Loupis-Geller A; Haas RH
    Mol Genet Metab; 2004; 83(1-2):138-49. PubMed ID: 15464428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effect of DCA treatment on the pyruvate dehydrogenase complex in patients with severe PDHC deficiency.
    Fouque F; Brivet M; Boutron A; Vequaud C; Marsac C; Zabot MT; Benelli C
    Pediatr Res; 2003 May; 53(5):793-9. PubMed ID: 12621116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of thiamine treatment in a child with Leigh disease due to thiamine-responsive pyruvate dehydrogenase deficiency.
    Di Rocco M; Lamba LD; Minniti G; Caruso U; Naito E
    Eur J Paediatr Neurol; 2000; 4(3):115-7. PubMed ID: 10872106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrum of neurological and survival outcomes in pyruvate dehydrogenase complex (PDC) deficiency: lack of correlation with genotype.
    DeBrosse SD; Okajima K; Zhang S; Nakouzi G; Schmotzer CL; Lusk-Kopp M; Frohnapfel MB; Grahame G; Kerr DS
    Mol Genet Metab; 2012 Nov; 107(3):394-402. PubMed ID: 23021068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dichloroacetate stabilizes the intraoperative acid-base balance during liver transplantation.
    Shangraw RE; Lohan-Mannion D; Hayes A; Moriarty RM; Fu R; Robinson ST
    Liver Transpl; 2008 Jul; 14(7):989-98. PubMed ID: 18581513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial pyruvate decarboxylase deficiency with profound lactic acidosis and hyperammonemia: responses to dichloroacetate and benzoate.
    McCormick K; Viscardi RM; Robinson B; Heininger J
    Am J Med Genet; 1985 Oct; 22(2):291-9. PubMed ID: 4050860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pathogenic glutamate-to-aspartate substitution (D296E) in the pyruvate dehydrogenase E1 subunit gene PDHA1.
    Brown RM; Head RA; Boubriak II; Leonard JV; Brown GK
    Hum Mutat; 2003 Dec; 22(6):496-7. PubMed ID: 14635113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics of dichloroacetate in children with lactic acidosis due to severe malaria.
    Krishna S; Agbenyega T; Angus BJ; Bedu-Addo G; Ofori-Amanfo G; Henderson G; Szwandt IS; O'Brien R; Stacpoole PW
    QJM; 1995 May; 88(5):341-9. PubMed ID: 7796089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dose dependent effects of dichloroacetate on lactic acidosis in dogs].
    Fujita Y; Fukui A; Yoshida H; Ohsumi A; Sakai T; Takaori M
    Masui; 1989 Aug; 38(8):1005-11. PubMed ID: 2810694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial.
    Kaufmann P; Engelstad K; Wei Y; Jhung S; Sano MC; Shungu DC; Millar WS; Hong X; Gooch CL; Mao X; Pascual JM; Hirano M; Stacpoole PW; DiMauro S; De Vivo DC
    Neurology; 2006 Feb; 66(3):324-30. PubMed ID: 16476929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disorders of pyruvate metabolism.
    De Meirleir L
    Handb Clin Neurol; 2013; 113():1667-73. PubMed ID: 23622387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.